1
Registration Hotline: +65 6514 3180 www.ibc-asia.com/biopharmasia www.ibc-asia.com Life Sciences Organised by Premier Media Partner Media Partners Technology Session Sponsor BioPharm Asia 2008 3rd Annual ASIA Monday 8 – Thursday 11 September 2008, Sheraton Towers Hotel, Singapore Pay ONE PRICE and Attend ANY TALK from the TWO CONFERENCES 2 Conferences | 1 Premier Exhibition | Additional Symposium | 45+ International Speakers | 200+ Participants Dr Xiaoming (Jerry) Yang, Scientific Director, Process and Product Development, Amgen Inc., USA Dr Tim Oldham, President – Asia Pacific, Hospira, Australia Dr Micheal D Kowolenko, Senior Vice President, Biotech Operating Unit, TO&PS, Wyeth Biotech, USA CONFERENCE 1: BIOMANUFACTURING CONFERENCE 2: BIOSIMILARS Dr Robert D. Kiss, Director – Late Stage Cell Culture, Process R&D, Genentech, Inc. Dr Subinay Ganguly, Director, BIO Pharm Development and Marketed Product Support, Centocor R&D, Inc. Dr Wei Gu, Process Development, Morphotek Dr Wen Bin Lai, Director of Process Development, SingVax Dr Tadayoshi Kawasaki, President and CEO, GlycoGene, Inc. Dr Kristopher A Barnthouse, Associate Director Process Technology/ Purification Technology, Global Biologics Supply Chain, LLC, Johnson & Johnson Dr Kym Baker, Head of Process Scale Up and Support, Operations Group, Lonza Biologics Plc Dr Jeremy Guo, Senior Scientist, Drug Product Device Development, Amgen Inc. Dr Geoffrey Allan, President and CEO, Insmed Incorporated Dr Lim Teck Onn, Director of the Clinical Research Centre, Ministry of Health, Malaysia Ranajit Sen, Vice President – Business Development, Shantha Biotechnics Ltd Dr Sriram Akundi, Head of Quality and Regulatory, Biocon Dr Niranjan Kumar, Senior VP, Biotech SBU, Wockhardt Professor Lucia Del Vecchio, Department of Nephrology and Dialysis, A. Manzoni Hospital Dr Corinna Sonderegger, Biopharmaceutical Operations, Group-Head Cell Biology & Media Development, Sandoz Dr Samir Sangitrao, Head of Regulatory Affairs, Intas Biopharma Dr Michael Hwang, President, Mycenax POST-CONFERENCE SYMPOSIUM: BIOPHARMACEUTICAL CONTRACT MANUFACTURING & PARTNERING TWO BRAND NEW WORKSHOPS, FIRST TIME IN ASIA! William Downey, President, Hightech Business Decisions Dr Lee Mermelstein, Senior Director, Process and Product Development, Alvine Pharmaceuticals, Inc. Dr Milind Antani, Head – Biotechnology and Pharmaceutical Industries Practice Group, Nishith Desai Associates Dr Joseph Chandler, President, Maine Biotechnology Services Julius Li, CEO, AutekBio, Inc. Jay Madan, Vice President of Business Development, Reliance Biopharmaceuticals PRE-CONFERENCE WORKSHOP: UNDERSTANDING BIOPHARMACEUTICALS Explore the critical influence of biopharmaceuticals derived from recombinant DNA technologies in the practice of medicine and in the development of the pharmaceutical industry POST-CONFERENCE WORKSHOP: EXPRESSION SYSTEMS FOR ANTIBODIES AND THEIR FRAGMENTS Get an overview of the various expression systems available and equip yourself with an understanding of the newest technologies and methods for expressing antibodies and their fragments in order to enable improved process optimisation and quality control! For more information, please contact Greg Moyle at IBC Asia (S) Pte Ltd. Tel : (65) 6835 5107 Fax: (65) 6733 5087 or Email: [email protected] or mail to IBC Asia (S) Pte Ltd, No. 1 Grange Road, #08-02, Orchard Building, Singapore 239693. Yes, please send me a brochure on: BioPharm Asia • 8–11 September 2008 • Sheraton Towers Hotel, Singapore I am unable to attend this time but please put me on your mailing list. IBC_BioPharm_Canbiotech_FA.indd 1 16/6/08 10:56:24 AM
